Hindustan Unilever Limited (HUL) has reported a complex financial performance for the quarter ending December 2025 (Q3 FY26), characterized by significant accounting shifts and a strategic pivot toward high-growth wellness categories. Financial Performance Highlights The company posted a consolidated revenue of **16,197 crore**, representing a **6%** increase compared to the same period last year. This growth was underpinned by a **4%** underlying volume expansion, indicating steady consumer demand despite a shifting economic backdrop. The headline net profit saw a dramatic surge of **121%**, reaching **6,603 crore**. However, this figure was primarily driven by a massive one-off exceptional gain of **4,611 crore** following the demerger of the company's ice cream business into Kwality Wall’s (India). Core Profitability and Margins Beyond the one-off gains, the core financial health reflected ongoing challenges. The Profit After Tax (PAT) from continuing operations—which excludes the ice cream business and other exceptional items—actually declined by **30%** to **2,118 crore**. Operating margins faced pressure from persistent input costs and the implementation of new national Labour Codes, which created an incremental liability of **113 crore**. Consequently, the EBITDA margin softened by **70 basis points** to settle at **23.3%**. Market Dynamics and Consumer Trends Rural markets have emerged as a primary growth engine, outperforming urban areas for the seventh consecutive quarter. Rural volume growth reached **8.4%**, nearly double the **4.6%** growth seen in cities. This resurgence is supported by: * Easing food inflation and stable commodity prices * Supportive government policies and rural welfare spending * High consumer interest in "Premium" products within rural segments Strategic Realignment HUL is aggressively reshaping its portfolio to focus on high-margin sectors. A key highlight is the full acquisition of Zywie Ventures (**OZiva**) for **824 crore**, signaling a "double down" on the health and wellbeing space. Simultaneously, the company has exited underperforming ventures like Nutritionalab to streamline operations. Market Outlook and Valuation Following the earnings announcement on **February 12, 2026**, HUL shares saw an intra-day decline of approximately **3.6%**, trading around **2,368–2,400**. Investors remain cautious regarding core margin compression despite the strong rural recovery. Management anticipates a stronger performance in the next fiscal year (**FY27**), banking on portfolio optimization and the benefits of a deflationary commodity environment to restore core profitability.